The era of precision medicine is now.

TSH provide various convenient, time-saving, and accurate detection.

• Disease screening

  Current risk assessment

  

  • Minimally invasive.
  • Development based on large clinical study in Taiwan, first in the world.
  • Fast and accurately evaluate endometrial cancer risk.

• Disease Monitor

  Surgery or treatment follow-up

  

  • Non-invasive liquid biopsy (ctDNA or CTC).
  • Real-time monitoring.
  • ctDNA NGS sequencing.
  • CTC test based on large CRC clinical study in Taiwan.
  • MRD follow-up.

• Medication Guidelines

  Comprehensive targeted therapies survey

  

  • Low false negativity and positivity ctDNA liquid biopsy.
  • Actionable drug related genes panel.
  • Flexible testing choices (body fluid / blood).
  • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)

  

  • Low false negativity and positivity tissue biopsy.
  • Actionable drug related genes panel.
  • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)

  

  • Low false negativity and positivity tissue biopsy.
  • DNA and RNA NGS sequencing.
  • Actionable drug related genes panel.
  • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)

  

  • Guideline Recommended(ASCO / ESMO / NCCN / NICE/ St. Gallen)
  • More comprehensive information
    • Risk Group
    • Risk of Recurrence
    • Probability of Distant Recurrence
    • Intrinsic Subtype